Related Experiment Video
Updated: Oct 4, 2025

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice
Published on: May 15, 2019
Effect of Glucocorticoid and 11β-Hydroxysteroid-Dehydrogenase Type 1 (11β-HSD1) in Neurological and Psychiatric
Seetal Dodd1,2, David R Skvarc1,3, Olivia M Dean1,4
1Deakin University, The Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Barwon Health, Geelong, Australia.
Abstract:
11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity is implicated as a moderator of the progression of multiple diseases and disorders in medicine and is actively subject to investigation as a therapeutic target. Here we summarize the mechanisms of the enzyme and detail the novel agents under investigation. Such agents modulate peripheral cortisol and cortisone levels in hypertension, type 2 diabetes, metabolic disorders, and Alzheimer's disease models, but there is mixed evidence for transduction into symptom management. There is inchoate evidence that 11β-HSD1 modulators may be useful pharmacotherapies for clinical improvement in psychiatry and neurology; however, more research is required.
Insights
11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is a key enzyme in disease progression and a therapeutic target. Novel agents targeting 11β-HSD1 show potential for treating metabolic and neurological disorders, but more research is needed.
Area of Science:
- Biochemistry
- Pharmacology
- Endocrinology
Background:
- 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) plays a crucial role in regulating active cortisol levels.
- Dysregulation of 11β-HSD1 is linked to various diseases, including metabolic syndrome, type 2 diabetes, and neurodegenerative disorders.
- 11β-HSD1 is an attractive therapeutic target for managing these conditions.
Purpose of the Study:
- To summarize the enzymatic mechanisms of 11β-HSD1.
- To review novel therapeutic agents targeting 11β-HSD1.
- To evaluate the potential of 11β-HSD1 modulators in disease management.
Main Methods:
- Literature review of enzymatic mechanisms.
- Analysis of preclinical and clinical studies on novel 11β-HSD1 inhibitors and activators.
- Examination of evidence for symptom management in various disease models.
Main Results:
- 11β-HSD1 modulators affect peripheral cortisol and cortisone levels.
- Agents show promise in models of hypertension, type 2 diabetes, metabolic disorders, and Alzheimer's disease.
- Evidence for clinical symptom management is mixed, with emerging data in psychiatric and neurological conditions.
Conclusions:
- 11β-HSD1 is a significant therapeutic target with potential applications across multiple medical fields.
- Novel agents modulating 11β-HSD1 activity warrant further investigation for their efficacy in disease treatment.
- More research is required to establish the clinical utility of 11β-HSD1 modulators, particularly in psychiatry and neurology.
More Related Videos
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Hypothalamic-Pituitary Axis
Drugs Affecting Neurotransmitter Synthesis
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Hormones of the Adrenal Glands
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...

